98%
921
2 minutes
20
Symptomatic benign prostatic hyperplasia is a common condition in the aging population that results in bothersome lower urinary tract symptoms and decreased quality of life. Patients often are treated with medication and offered surgery for persistent symptoms. Transurethral resection of the prostate is considered the traditional standard of care, but several minimally invasive surgical treatments also are offered. Prostatic artery embolization (PAE) is emerging as an effective treatment option with few reported adverse effects, minimal blood loss, and infrequent overnight hospitalization. The procedure is offered to patients with moderate to severe lower urinary tract symptoms and depressed urinary flow due to bladder outlet obstruction. Proper patient selection and meticulous embolization are critical to optimize results. To perform PAE safely and avoid nontarget embolization, interventional radiologists must have a detailed understanding of the pelvic arterial anatomy. Although the prostatic arteries often arise from the internal pudendal arteries, several anatomic variants and pelvic anastomoses are encountered. Prospective cohort studies, small randomized controlled trials, and meta-analyses have shown improved symptoms after treatment, with serious adverse effects occurring rarely. This article reviews the basic principles of PAE that must be understood to develop a thriving PAE practice. These principles include patient evaluation, review of surgical therapies, details of pelvic arterial anatomy, basic principles of embolization, and an overview of published results. RSNA, 2019.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1148/rg.2019180195 | DOI Listing |
Zhonghua Nan Ke Xue
August 2025
Department of Interventional Therapy, General Hospital of Eastern Theater Command, Nanjing, Jiangsu 210002, China.
Objective: To investigate the effect of innovative perioperative pain management on prostate cancer patients with hematuria undergoing prostatic artery embolization (PAE).
Methods: A total of 60 patients undergoing PAE in the Interventional Therapy Department of General Hospital of Eastern Theater Command from May 2024 to January 2025 were selected by convenience sampling method and randomly divided into the intervention group and the control group, with 30 patients in each group. The control group received traditional pain management of nursing.
Urol Oncol
September 2025
Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL; Surgery Service, Jesse Brown VA Medical Center, Chicago, IL.
Introduction: Renal artery pseudoaneurysm (RAP) is a life-threatening complication of partial nephrectomy (PN) with reported rates of 1% to 2%. No studies have reported on the association between intraoperative blood pressure (BP) and RAP.
Methods: We identified all PN patients in our system between 2010 and 2024 and identified those with RAP (cases).
Cardiovasc Intervent Radiol
September 2025
Interventional and Neuroendovascular Radiology Department, Acibadem Kent Hospital, 8229/1. Sk. No:56 Cigli, Ataşehir, İzmir, Türkiye.
Minerva Urol Nephrol
August 2025
Department of Urology, MRC Centre for Transplantation, King's College London, London, UK.
Introduction: Technological advancements in minimally invasive surgical therapies(MIST) have altered the management of benign prostatic hyperplasia (BPH), offering reduced morbidity and better preservation of sexual functions compared to traditional surgical methods. The study aimed to systematically evaluate the effects of MISTs on erectile and ejaculatory functions in patients with BPH.
Evidence Acquisition: A systematic literature search was performed in Medline(PubMed), Embase (Ovid), and Cochrane Library (up to December 2024) following PRISMA guidelines (PROSPEROCRD42024541279).
Eur Radiol
August 2025
Department of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, Dijon, France.
Objectives: To assess 12-month outcomes of prostate artery embolization (PAE) using N-butyl cyanoacrylate (NBCA) glue in patients with incapacitating lower-urinary-tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
Materials And Methods: Retrospective single-center observational study of patients evaluated 12 months after PAE done in 2018-2023 using methacryloxysulfolane-NBCA mixed with ethiodized oil. Glue injection was under free- or blocked-flow conditions, depending on artery size and real-time assessment of penetration.